Literature DB >> 35608618

[A contrast medium uptake of the vessel wall is not specific for cerebral vasculitis].

Jana Becker1, Peter Berlit2, Oliver Kastrup3, Simon Schuster4, Daniel Strunk5, Roland Veltkamp5,6, Markus Kraemer5,7.   

Abstract

Entities:  

Year:  2022        PMID： 35608618     DOI： 10.1007/s00115-022-01304-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  10 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

2.  Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.

Authors:  Mahmud Mossa-Basha; Adam de Havenon; Kyra J Becker; Danial K Hallam; Michael R Levitt; Wendy A Cohen; Daniel S Hippe; Matthew D Alexander; David L Tirschwell; Thomas Hatsukami; Catherine Amlie-Lefond; Chun Yuan
Journal:  Stroke       Date:  2016-06-07       Impact factor: 7.914

3.  Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases?

Authors:  J Linn; G Fesl; C Ottomeyer; A Straube; M Dichgans; H Bruckmann; T Pfefferkorn
Journal:  Cephalalgia       Date:  2011-01-10       Impact factor: 6.292

4.  Vessel wall signal enhancement on 3-T MRI in acute stroke patients after stent retriever thrombectomy.

Authors:  Peter Abraham; J Scott Pannell; David R Santiago-Dieppa; Vincent Cheung; Jeffrey Steinberg; Arvin Wali; Mihir Gupta; Robert C Rennert; Roland R Lee; Alexander A Khalessi
Journal:  Neurosurg Focus       Date:  2017-04       Impact factor: 4.047

5.  Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes.

Authors:  Mahmud Mossa-Basha; William D Hwang; Adam De Havenon; Daniel Hippe; Niranjan Balu; Kyra J Becker; David T Tirschwell; Thomas Hatsukami; Yoshimi Anzai; Chun Yuan
Journal:  Stroke       Date:  2015-05-07       Impact factor: 7.914

6.  Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis?

Authors:  L Kraayvanger; P Berlit; P Albrecht; H-P Hartung; M Kraemer
Journal:  Clin Exp Immunol       Date:  2018-07-23       Impact factor: 4.330

7.  High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis.

Authors:  E C Obusez; F Hui; R A Hajj-Ali; R Cerejo; L H Calabrese; T Hammad; S E Jones
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

8.  Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitis.

Authors:  Daniel Strunk; Roland Veltkamp; Sven G Meuth; René Chapot; Markus Kraemer
Journal:  Neurol Res Pract       Date:  2022-02-28

9.  Vascular wall imaging in reversible cerebral vasoconstriction syndrome - a 3-T contrast-enhanced MRI study.

Authors:  Chun-Yu Chen; Shih-Pin Chen; Jong-Ling Fuh; Jiing-Feng Lirng; Feng-Chi Chang; Yen-Feng Wang; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2018-08-30       Impact factor: 7.277

10.  Diagnosis and follow-up evaluation of central nervous system vasculitis: an evaluation of vessel-wall MRI findings.

Authors:  Maximilian Patzig; Robert Forbrig; Clemens Küpper; Ozan Eren; Tobias Saam; Lars Kellert; Thomas Liebig; Florian Schöberl
Journal:  J Neurol       Date:  2021-07-08       Impact factor: 4.849
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.